Rui Castro

Has grant

Invited Assistant Professor

Faculty of Pharmacy, University of Lisbon

Portugal

Research Interests

Explore related searches

Professors in Portugal Professors in Cancer Biology Cancer Biology professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rui Castro is an Invited Assistant Professor at the Faculty of Pharmacy, University of Lisbon, Portugal. His research areas encompass cholangiocarcinoma, liver diseases, and the impact of aging on liver cancer. He has contributed significantly to understanding the relationship between liver dysfunction and metabolic diseases, as well as the efficacy of patient education in biliary tract cancer.

Recent Grants

Grant: Close

Fat2LiverTGR5 - Targeting the adipose tissue to treat fatty liver: role of TGR5

Open Date: 2019-09-01

Close Date: 2022-09-01

Grant: Close

Targeting aquaporin-3 as a novel therapeutic approach for melanoma

Open Date: 2018-10-01

Close Date: 2021-09-01

Grant: Close

Exosomal Fat-Liver Axis in Non-Alcoholic Fatty Liver Disease: Function and Modulation

Open Date: 2018-09-01

Close Date: 2021-08-01

Grant: Close

Metabolic Control of Neural Repair by Diet and Gut Microbiome during Aging

Open Date: 2018-09-01

Close Date: 2021-08-01

Grant: Close

TITANIC - CYP46A1 as a new TherapeutIcTAarget in NIemann-Pick type C disease

Open Date: 2018-08-01

Close Date: 2021-07-01

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (20)

Carina Prip-Buus

CNRS Délégation Paris B

FRANCE

Rui Castro

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models

Bridging the equity gap in patient education: the biliary tract cancer BABEL project

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease

Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD

Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice

Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma

Collaborators (20)

Carina Prip-Buus

Marta Afonso

Monique Verstegen

Luke Boulter

Rocio I. R. Macias

Madalena Pimentel

Jesus M. Banales

Jose Marin

Laura Fouassier

José Teixeira

Luc van der Laan

Mohammed Moustapha Anwar

Sergio A. Gradilone

Liana C. Silva

LUCA FABRIS

Patricia Aspichueta

Jérémie Gautheron

Chiara Braconi

Massimiliano Cadamuro

Maria J. Monte

Make your next move.